- Home
- PCRX vs CTO Comparison
PCRX vs CTO Comparison
Compare PCRX & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CTO
- Stock Information
- Founded
- PCRX 2006
- CTO 1902
- Country
- PCRX United States
- CTO United States
- Employees
- PCRX N/A
- CTO N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CTO Real Estate Investment Trusts
- Sector
- PCRX Health Care
- CTO Real Estate
- Exchange
- PCRX Nasdaq
- CTO Nasdaq
- Market Cap
- PCRX 604.7M
- CTO 578.8M
- IPO Year
- PCRX 2011
- CTO N/A
- Fundamental
- Price
- PCRX $20.55
- CTO $19.43
- Analyst Decision
- PCRX Buy
- CTO Strong Buy
- Analyst Count
- PCRX 10
- CTO 4
- Target Price
- PCRX $27.60
- CTO $21.50
- AVG Volume (30 Days)
- PCRX 779.4K
- CTO 448.8K
- Earning Date
- PCRX 02-27-2025
- CTO 02-20-2025
- Dividend Yield
- PCRX N/A
- CTO 7.81%
- EPS Growth
- PCRX N/A
- CTO N/A
- EPS
- PCRX N/A
- CTO 0.61
- Revenue
- PCRX $694,957,000.00
- CTO $118,662,000.00
- Revenue This Year
- PCRX $4.83
- CTO N/A
- Revenue Next Year
- PCRX $2.16
- CTO $13.12
- P/E Ratio
- PCRX N/A
- CTO $32.08
- Revenue Growth
- PCRX 4.40
- CTO 16.61
- 52 Week Low
- PCRX $11.16
- CTO $16.16
- 52 Week High
- PCRX $34.01
- CTO $21.15
- Technical
- Relative Strength Index (RSI)
- PCRX 61.87
- CTO 45.84
- Support Level
- PCRX $18.18
- CTO $18.89
- Resistance Level
- PCRX $22.36
- CTO $19.74
- Average True Range (ATR)
- PCRX 0.97
- CTO 0.37
- MACD
- PCRX 0.11
- CTO -0.02
- Stochastic Oscillator
- PCRX 56.80
- CTO 52.94
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a Florida-based real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.